医疗特长：从事恶性肿瘤综合治疗多年，擅长鼻咽癌、喉癌、下咽癌、口咽癌、副鼻窦恶性肿瘤的放射治疗及个体化综合治疗。教育经历：2011.9 - 2014.07 中山大学附属第一医院，肿瘤学(放射治疗方向)，博士2012.9 - 2012.12 美国Albert Einstein医学院Beth Israel癌症中心，Clinical Observer2004.9 - 2007.7 中山大学肿瘤防治中心，肿瘤学(放射治疗方向)，硕士1998.9 - 2003.7 郑州大学，临床医学，学士工作经历：2014.07-至今 中山大学附属第一医院放射治疗科工作2010.07-2011.08 中山大学附属第五医院放疗科，住院医师2007.08-2010.07 中山大学肿瘤防治中心，放射肿瘤学专科培训医师。代表作：Induction chemotherapy regimen of docetaxel plus cisplatin versus docetaxel, cisplatin plus fluorouracil followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Preliminary results of an open-label, noninferiority, multicentre, randomised, controlled phase 3 trial. Lancet Eclinicalmedicine，2022； IF=17.033Pretreatment BMI as an independent prognostic factor in patients with locoregionally advanced NPC treated with chemoradiotherapy: Findings from a randomized trial. EJC，2013； IF=10.002Association between Pretreatment Serum High-density Lipoprotein Cholesterol and Treatment Outcomes in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy: Findings from a Randomised Trial.JOC，2019； IF=4.478